Article
Immunohistochemistry for myc predicts survival in colorectal cancer.
PloS one - 1 Jan 2014
Toon Christopher W, Chou Angela, Clarkson Adele, DeSilva Keshani, Houang Michelle, Chan Joseph C Y, Sioson Loretta L, Jankova Lucy, Gill Anthony J
Abstract excerpt
MYC over-expression as determined by molecular means has been reported as a favorable prognostic biomarker in colorectal carcinoma (CRC). However MYC expression analysis is not available in the routine clinical setting. We investigated whether immunohistochemistry (IHC) for the myc protein using a novel commercially available rabbit monoclonal antibody [clone Y69] which is currently in widespread clinical use for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.